comparemela.com

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]

Related Keywords

Cyrus Harmon , Clarivest Asset Management , Silverarc Capital Management , Goldman Sachs Group , Olema Pharmaceuticals , Quarter For Olema Pharmaceuticals , Victory Capital Management Inc , News Ratings For Olema Pharmaceuticals Daily , Nasdaq , Vivo Capital , Olema Pharmaceuticals Inc , Institutional Investors Weigh In On Olema Pharmaceuticals , Olema Pharmaceuticals Trading , Get Free Report , Director Cyrus Harmon , Capital Management , Vest Asset Management , One Financial , Olema Pharmaceuticals Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.